Venture Capital

With a new Dubai office and MD, Asia Bankers Club aims to bridge global capital flows, leveraging the city's rise as an investment command center.

An Innventure company proves its technology can turn real-world plastic trash into valuable chemicals, but can it navigate the path to commercialization?

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Palo Alto Networks acquires Koi for a reported $400M, aiming to secure the new 'Agentic Endpoint' and define the next era of enterprise AI security.

The toy giant unveils its 2026 lineup, blending high-tech pets with purposeful play and making a bold, strategic move into the lucrative adult gaming market.

A new series from A3 and BBC StoryWorks moves beyond efficiency to show how automation is augmenting human lives in healthcare, education, and more.

At a key conference, DocGo's CEO will navigate financial headwinds while promoting a vision for proactive, tech-enabled healthcare delivery.

Boundless Futures Foundation and Ladies Who Launch partner to provide funding and vital resources, creating a new ecosystem for mission-driven female founders.

Ceva's AI licensing revenue soared in 2025, securing deals with a top PC OEM and Microchip, signaling a major industry shift to on-device intelligence.

Ahead of its March 3 earnings call, 908 Devices' strong preliminary results and focus on handheld tech signal a pivotal year for the security innovator.

Shutterstock posts record 2025 revenue on AI data growth, but a steep Q4 loss and merger costs reveal deep challenges in its core content business.

Ascend Elements' award to TDK Ventures reveals a new VC model, where hands-on partnership is key to building a secure, circular battery supply chain.

Tech giant Sony secures access to crucial 5G, Wi-Fi, and video patents, renewing a long-standing agreement with R&D powerhouse InterDigital.

Fortrea splits key roles, dedicating its CMO to scientific strategy and hiring a new president for clinical pharmacology in a bold post-spin-off move.

As Pasithea Therapeutics heads to a key investor conference, all eyes are on its lead drug, PAS-004, and its potential to treat rare and complex diseases.

Landmark Phase 3 trial results show psilocybin offers rapid, lasting relief for severe depression, pushing psychedelic medicine closer to the mainstream.

With 13,000 attendees and a bold expansion to Ras Al Khaimah, AIBC Eurasia 2026 highlights a major shift of tech's center of power to the East.

Allocate's 350% asset growth signals a major shift as wealth advisors embrace private markets. Discover how its AI-powered platform is making it possible.

A new global championship aims to unify competitive barbecue, offering a $1M prize and a path from local cook-offs to a Las Vegas world final.

New Commerce Dept. duties on Chinese graphite aim to reshape the U.S. battery industry, but will it secure the supply chain or just raise EV costs?